Literature DB >> 15554387

Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination.

Fernando A Fierro1, Walter D Sierralta, Maria J Epuñan, José J Minguell.   

Abstract

Marrow stroma represents an advantageous environment for development of micrometastatic cells. Within the cellular structure of marrow stroma, mesenchymal stem cells (MSC) have been postulated as an interacting target for disseminated cancer cells. The studies reported here were performed to gain more information on the interaction of the human breast cancer cell line MCF-7 with human bone marrow-derived MSC cells and to investigate whether this interaction affects tumor cell properties. The results showed that after co-culture with MSC, changes were detected in the morphology, proliferative capacity and aggregation pattern of MCF-7 cells, but these parameters were not affected after the co-culture of MSC cells with a non-tumorigenic breast epithelial cell line, MCF-10. Since the indirect culture of MCF-7 with MSC or its products also resulted in functional changes in the tumor cells, we evaluated whether these effects could be attributed to growth factors produced by MSC cells. It was found that VEGF and IL-6 mimic the effects produced by MSC or its products on the proliferation and aggregation properties of MCF-7, cells, respectively. Thus, it seems that after entry of disseminated tumor cells into the marrow space, their proliferative and morphogenetic organization patterns are modified after interaction with distinct stromal cells and/or with specific signals from the marrow microenvironment.

Entities:  

Mesh:

Year:  2004        PMID: 15554387     DOI: 10.1023/b:clin.0000046130.79363.33

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

Review 1.  Mesenchymal stem cells.

Authors:  J J Minguell; A Erices; P Conget
Journal:  Exp Biol Med (Maywood)       Date:  2001-06

2.  Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors.

Authors:  J P Lévesque; D N Haylock; P J Simmons
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

3.  N-cadherin promotes adhesion between invasive breast cancer cells and the stroma.

Authors:  R B Hazan; L Kang; B P Whooley; P I Borgen
Journal:  Cell Adhes Commun       Date:  1997-03

4.  Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.

Authors:  E Borgen; B Naume; J M Nesland; G Kvalheim; K Beiske; O Fodstad; I Diel; E F Solomayer; P Theocharous; R C Coombes; B M Smith; E Wunder; J P Marolleau; J Garcia; K Pantel
Journal:  Cytotherapy       Date:  1999       Impact factor: 5.414

5.  Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors.

Authors:  P A Conget; C Allers; J J Minguell
Journal:  J Hematother Stem Cell Res       Date:  2001-12

6.  Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  Alejandro Erices; Paulette Conget; Cecilia Rojas; José J Minguell
Journal:  Exp Cell Res       Date:  2002-10-15       Impact factor: 3.905

Review 7.  Mitochondrial morphology in human fetal and adult female germ cells.

Authors:  P M Motta; S A Nottola; S Makabe; R Heyn
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

8.  Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

Authors:  G Wiedswang; E Borgen; R Kåresen; G Kvalheim; J M Nesland; H Qvist; E Schlichting; T Sauer; J Janbu; T Harbitz; B Naume
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

Review 9.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

10.  Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.

Authors:  Joachim Bischoff; Robert Rosenberg; Michael Dahm; Wolfgang Janni; Klaus Gutschow
Journal:  Recent Results Cancer Res       Date:  2003
View more
  20 in total

1.  Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells.

Authors:  Jaehyup Kim; Leah E Escalante; Bridget A Dollar; Summer E Hanson; Peiman Hematti
Journal:  Cancer Invest       Date:  2013-09-10       Impact factor: 2.176

Review 2.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

4.  Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.

Authors:  F Böhrnsen; M Fricke; C Sander; A Leha; H Schliephake; F J Kramer
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

5.  Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis.

Authors:  Valeria B Fernández Vallone; Erica L Hofer; Hosoon Choi; Raúl H Bordenave; Emilio Batagelj; Leonardo Feldman; Vincent La Russa; Daniela Caramutti; Federico Dimase; Vivian Labovsky; Leandro M Martínez; Norma A Chasseing
Journal:  Clin Exp Metastasis       Date:  2012-09-30       Impact factor: 5.150

6.  Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.

Authors:  Lyndsay V Rhodes; Shannon E Muir; Steven Elliott; Lori M Guillot; James W Antoon; Patrice Penfornis; Syreeta L Tilghman; Virgilio A Salvo; Juan P Fonseca; Michelle R Lacey; Barbara S Beckman; John A McLachlan; Brian G Rowan; Radhika Pochampally; Matthew E Burow
Journal:  Breast Cancer Res Treat       Date:  2009-07-12       Impact factor: 4.872

Review 7.  Concise review: adult multipotent stromal cells and cancer: risk or benefit?

Authors:  Gwendal Lazennec; Christian Jorgensen
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

8.  Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.

Authors:  Lyndsay V Rhodes; James W Antoon; Shannon E Muir; Steven Elliott; Barbara S Beckman; Matthew E Burow
Journal:  Mol Cancer       Date:  2010-11-18       Impact factor: 27.401

9.  Differential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture.

Authors:  Andy Shau-Bin Chou; Hsin-Yi Wang; Hung-Chang Chen; Ming-Hsiu Tsai; Cheng-Keng Chuang; Shuen-Kuei Liao
Journal:  BMC Cancer       Date:  2009-06-05       Impact factor: 4.430

10.  hMSCs possess the potential to differentiate into DP cells in vivo and in vitro.

Authors:  Minjuan Wu; Qing Sun; Xiaocan Guo; Houqi Liu
Journal:  Cell Biol Int Rep (2010)       Date:  2012-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.